Kumar Prateek, Salazar-Marioni Sergio, Dhanjani Saagar, Iyyangar Ananya, Abdelkhaleq Rania, Tariq Muhammad Bilal, Niktabe Arash, Ballekere Anjan N, Le Ngoc Mai, Azeem Hussain, McCullough Louise, Sheth Sunil A, Lee Eunyoung
Department of Neurology, McGovern Medical School at UTHealth, Houston, Texas, USA.
Rice University, Houston, Texas, USA.
J Neurointerv Surg. 2024 Aug 30. doi: 10.1136/jnis-2024-022192.
There is substantial interest in adding endovascular stroke therapy (EST) capabilities in community hospitals. Here, we assess the effect of transitioning to an EST-performing hospital (EPH) on acute ischemic stroke (AIS) admissions in a large hospital system including academic and community hospitals.
From our prospectively collected multi-institutional registry, we collected data on AIS admissions at 10 hospitals in the greater Houston area from January 2014 to December 2022: one longstanding EPH (group A), three community hospitals that transitioned to EPHs in November 2017 (group B), and six community non-EPHs that remained non-EPH (group C). Primary outcomes were trends in total AIS admissions, large vessel occlusion (LVO) and non-LVO AIS, and tissue plasminogen activator (tPA) and EST use.
Among 20 317 AIS admissions, median age was 67 (IQR 57-77) years, 52.4% were male, and median National Institutes of Health Stroke Scale (NIHSS) was 4 (IQR 1-10). During the first 12 months after EPH transition, AIS admissions increased by 1.9% per month for group B, with non-LVO stroke increasing by 4.2% per month (P<0.001). A significant change occurred for group A at the transition point for all outcomes with decreasing rates in admissions for AIS, non-LVO AIS and LVO AIS, and decreasing rates of EST and tPA treatments (P<0.001).
Upgrading to EPH status was associated with a 2% per month increase in AIS admissions during the first year post-transition for the upgrading hospitals, but decreasing volumes and treatments at the established EPH. These findings quantify the impact on AIS admissions in hospital systems with increasing EST access in community hospitals.
社区医院增加血管内卒中治疗(EST)能力受到广泛关注。在此,我们评估在一个包括学术医院和社区医院的大型医院系统中,转变为具备EST治疗能力的医院(EPH)对急性缺血性卒中(AIS)入院患者的影响。
从我们前瞻性收集的多机构登记数据中,我们收集了2014年1月至2022年12月大休斯顿地区10家医院AIS入院患者的数据:一家长期的EPH(A组),三家于2017年11月转变为EPH的社区医院(B组),以及六家仍为非EPH的社区医院(C组)。主要结局是AIS入院总数、大血管闭塞(LVO)和非LVO AIS以及组织型纤溶酶原激活剂(tPA)和EST使用情况的趋势。
在20317例AIS入院患者中,中位年龄为67岁(四分位间距57 - 77岁),52.4%为男性,美国国立卫生研究院卒中量表(NIHSS)中位值为4(四分位间距1 - 10)。在转变为EPH后的前12个月,B组AIS入院患者每月增加1.9%,非LVO卒中每月增加4.2%(P<0.001)。A组在转变点时所有结局均发生显著变化,AIS、非LVO AIS和LVO AIS的入院率下降,EST和tPA治疗率下降(P<0.001)。
升级为EPH状态与升级医院在转变后的第一年AIS入院患者每月增加2%相关,但老牌EPH的入院量和治疗量减少。这些发现量化了社区医院EST可及性增加对医院系统中AIS入院患者的影响。